LOSARTAN POTASSIUM

Losartan Potassium Adverse Events Reported to the FDA Over Time

How are Losartan Potassium adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Losartan Potassium, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Losartan Potassium is flagged as the suspect drug causing the adverse event.

Most Common Losartan Potassium Adverse Events Reported to the FDA

What are the most common Losartan Potassium adverse events reported to the FDA?

Renal Failure Acute	428 (1.63%)
Dizziness	397 (1.51%)
Blood Pressure Increased	378 (1.44%)
Hypotension	318 (1.21%)
Hyponatraemia	284 (1.08%)
Headache	267 (1.02%)
Diarrhoea	257 (.98%)
Dyspnoea	256 (.97%)
Hypertension	254 (.97%)
Malaise	250 (.95%)
Drug Interaction	242 (.92%)
	Show More
Hyperkalaemia	236 (.9%)
Drug Ineffective	232 (.88%)
Nausea	226 (.86%)
Asthenia	214 (.81%)
Rhabdomyolysis	214 (.81%)
Cough	212 (.81%)
Fatigue	207 (.79%)
Loss Of Consciousness	196 (.75%)
Dehydration	186 (.71%)
Fall	179 (.68%)
Renal Failure	175 (.67%)
Blood Creatinine Increased	172 (.65%)
Vomiting	166 (.63%)
Oedema Peripheral	163 (.62%)
Palpitations	161 (.61%)
Hypokalaemia	159 (.61%)
Product Substitution Issue	154 (.59%)
Syncope	141 (.54%)
Overdose	133 (.51%)
Feeling Abnormal	131 (.5%)
Blood Creatine Phosphokinase Increa...	130 (.49%)
Myalgia	130 (.49%)
Rash	129 (.49%)
Arthralgia	128 (.49%)
Cardiac Failure	127 (.48%)
Pneumonia	126 (.48%)
Pruritus	126 (.48%)
Renal Impairment	120 (.46%)
Angioedema	115 (.44%)
Confusional State	113 (.43%)
Blood Pressure Decreased	110 (.42%)
Chest Pain	109 (.41%)
Abdominal Pain	108 (.41%)
Pain In Extremity	108 (.41%)
Anaemia	107 (.41%)
Blood Urea Increased	105 (.4%)
Condition Aggravated	105 (.4%)
Pyrexia	105 (.4%)
Muscle Spasms	104 (.4%)
Heart Rate Increased	102 (.39%)
Hypoglycaemia	102 (.39%)
Back Pain	100 (.38%)
Myocardial Infarction	96 (.37%)
Pain	96 (.37%)
Atrial Fibrillation	93 (.35%)
Completed Suicide	92 (.35%)
Lactic Acidosis	92 (.35%)
Decreased Appetite	91 (.35%)
Death	89 (.34%)
Somnolence	87 (.33%)
Alanine Aminotransferase Increased	86 (.33%)
Blood Pressure Inadequately Control...	86 (.33%)
Abdominal Pain Upper	85 (.32%)
Cardiac Arrest	85 (.32%)
Cerebrovascular Accident	84 (.32%)
Bradycardia	83 (.32%)
Aspartate Aminotransferase Increase...	81 (.31%)
Insomnia	81 (.31%)
Convulsion	80 (.3%)
Gait Disturbance	79 (.3%)
Weight Decreased	78 (.3%)
Adverse Event	75 (.29%)
Metabolic Acidosis	73 (.28%)
Drug Exposure During Pregnancy	72 (.27%)
Blood Glucose Increased	71 (.27%)
Platelet Count Decreased	71 (.27%)
Pulmonary Oedema	70 (.27%)
Muscular Weakness	68 (.26%)
Abdominal Discomfort	67 (.25%)
Weight Increased	67 (.25%)
Blood Potassium Increased	65 (.25%)
Dysphagia	65 (.25%)
Interstitial Lung Disease	64 (.24%)
Medication Error	64 (.24%)
Pancytopenia	64 (.24%)
Diabetes Mellitus	62 (.24%)
Anuria	61 (.23%)
Drug Hypersensitivity	61 (.23%)
Tachycardia	61 (.23%)
Wrong Technique In Drug Usage Proce...	61 (.23%)
Anxiety	60 (.23%)
Swollen Tongue	60 (.23%)
Tremor	60 (.23%)
Hypoaesthesia	59 (.22%)
Urticaria	59 (.22%)
Cardiac Failure Congestive	58 (.22%)
Chest Discomfort	58 (.22%)
Hyperhidrosis	58 (.22%)
Thrombocytopenia	58 (.22%)
Depression	56 (.21%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Losartan Potassium, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Losartan Potassium is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Losartan Potassium

What are the most common Losartan Potassium adverse events reported to the FDA?

Neurological	1490 (5.67%)
Epidermal And Dermal Conditions	1029 (3.92%)
Renal Disorders	994 (3.78%)
Electrolyte And Fluid Balance Condi...	983 (3.74%)
Respiratory	944 (3.59%)
Cardiac And Vascular Investigations	890 (3.39%)
Gastrointestinal Signs	874 (3.33%)
Cardiac Arrhythmias	692 (2.63%)
Therapeutic And Nontherapeutic Effe...	659 (2.51%)
Muscle	599 (2.28%)
Decreased And Nonspecific Blood Pre...	576 (2.19%)
	Show More
Infections - Pathogen Unspecified	479 (1.82%)
Medication Errors	444 (1.69%)
Hematology Investigations	431 (1.64%)
Renal And Urinary Tract Investigati...	399 (1.52%)
Gastrointestinal Motility And Defec...	368 (1.4%)
Hepatic And Hepatobiliary	351 (1.34%)
Musculoskeletal And Connective Tiss...	339 (1.29%)
Hepatobiliary	336 (1.28%)
Joint	304 (1.16%)
Vascular Hypertensive	299 (1.14%)
Injuries	298 (1.13%)
Headaches	290 (1.1%)
Central Nervous System Vascular	282 (1.07%)
Coronary Artery	273 (1.04%)
Water, Electrolyte And Mineral	248 (.94%)
Cardiac Disorder Signs	236 (.9%)
Enzyme	234 (.89%)
Lower Respiratory Tract Disorders	233 (.89%)
Heart Failures	224 (.85%)
Anemias Nonhemolytic And Marrow Dep...	222 (.84%)
Metabolic, Nutritional And Blood Ga...	220 (.84%)
Glucose Metabolism Disorders	213 (.81%)
Product Quality Issues	213 (.81%)
Urinary Tract Signs	208 (.79%)
Physical Examination Topics	204 (.78%)
Anxiety Disorders	198 (.75%)
Skin Appendage Conditions	191 (.73%)
Angiedema And Urticaria	190 (.72%)
Acid-base	181 (.69%)
Appetite And General Nutritional	177 (.67%)
Allergic Conditions	172 (.65%)
Movement Disorders	162 (.62%)
Bone And Joint Injuries	158 (.6%)
Fatal Outcomes	148 (.56%)
Deliria	135 (.51%)
Oral Soft Tissue Conditions	135 (.51%)
Sleep Disorders	131 (.5%)
Body Temperature Conditions	130 (.49%)
Vision	127 (.48%)
Chemical Injury And Poisoning	120 (.46%)
Suicidal And Self-injurious Behavio...	118 (.45%)
Seizures	107 (.41%)
Nephropathies	105 (.4%)
Bronchial Disorders	103 (.39%)
Eye	99 (.38%)
Lifestyle Issues	99 (.38%)
Myocardial	99 (.38%)
Upper Respiratory Tract Disorders	98 (.37%)
White Blood Cell	97 (.37%)
Exocrine Pancreas Conditions	94 (.36%)
Arteriosclerosis, Stenosis, Vascula...	92 (.35%)
Mental Impairment	91 (.35%)
Inner Ear And Viiith Cranial Nerve	89 (.34%)
Tongue Conditions	78 (.3%)
Viral Infectious	77 (.29%)
Hematological And Lymphoid Tissue T...	75 (.29%)
Bacterial Infectious	74 (.28%)
Depressed Mood Disorders	74 (.28%)
Platelet	74 (.28%)
Skin Vascular Abnormalities	73 (.28%)
Vascular	70 (.27%)
Salivary Gland Conditions	69 (.26%)
Gastrointestinal Inflammatory Condi...	67 (.25%)
Cardiac Valve	66 (.25%)
Gallbladder	66 (.25%)
Gastrointestinal Hemorrhages	63 (.24%)
Peripheral Neuropathies	58 (.22%)
Gastrointestinal Ulceration And Per...	52 (.2%)
Protein And Chemistry Analyses	51 (.19%)
Disturbances In Thinking	50 (.19%)
Placental, Amniotic And Cavity Diso...	50 (.19%)
Lipid Analyses	48 (.18%)
Gastrointestinal Neoplasms Malignan...	46 (.18%)
Hypothalamus And Pituitary Gland	44 (.17%)
Pulmonary Vascular	44 (.17%)
Gastrointestinal Conditions	41 (.16%)
Ocular Infections, Irritations And ...	39 (.15%)
Psychiatric	39 (.15%)
Urolithiases	38 (.14%)
Encephalopathies	37 (.14%)
Leukemias	37 (.14%)
Bone Disorders	36 (.14%)
Embolism And Thrombosis	36 (.14%)
Therapeutic Procedures And Supporti...	36 (.14%)
Bone And Joint Therapeutic Procedur...	35 (.13%)
Connective Tissue Disorders	35 (.13%)
Coagulopathies And Bleeding Diathes...	34 (.13%)
Pleural	34 (.13%)
Musculoskeletal And Connective Tiss...	32 (.12%)
Procedural And Device Related Injur...	32 (.12%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Losartan Potassium, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Losartan Potassium is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.